GlassScriptPhysician profile
David T Ober
NPI 1952463861
$3,952.02
in general payments reported to CMS, 2019-2025
44 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
See the full distribution for Neuromuscular Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,624 · 2020: $317 · 2021: $18.07 · 2022: $498 · 2023: $447 · 2024: $344 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $868.56 | 2020-2025 | |
| Emd Serono, INC. | $282.84 | 2019-2022 | |
| Sk Life Science, INC. | $243.01 | 2022-2023 | Xcopri |
| Lilly USA, LLC | $202.73 | 2019-2025 | Kisunla |
| Genentech USA, INC. | $198.42 | 2019 | |
| Sunovion Pharmaceuticals INC. | $176.87 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $156.45 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $155.98 | 2024 | Gore Cardioform Septal Occluder |
| Argenx US, INC. | $125.00 | 2025 | Vyvgart |
| Horizon Therapeutics Plc | $123.21 | 2019 | |
| Allergan, INC. | $106.72 | 2019-2020 | |
| Philips North America LLC | $100.07 | 2023 | |
| Assertio Therapeutics, INC. | $94.68 | 2019 | |
| Genzyme Corporation | $81.61 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $75.64 | 2019-2020 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ober listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.